by Danielle Medeiros | Sep 23, 2020 | Events, Featured
EpiVax continues to “meet” with global clients despite pandemic restrictions through virtual meetings and conferences such as TIDES: Oligonucleotide and Peptide Therapeutics Virtual! In addition to participating in a Live Panel Discussion on FDA Draft...
by Danielle Medeiros | Aug 25, 2020 | Featured, News
PROVIDENCE, RI, August 24, 2020 /PRNewswire/ — EpiVax, Inc. (“EpiVax”), a Rhode Island-based company and recognized leader in the field of computational vaccinology, today announced it has out-licensed its COVID-19 vaccine candidate, EPV-CoV-19, to EpiVax...
by Danielle Medeiros | Aug 24, 2020 | Featured, Thinking Out Loud -Blog
Time for T? Or Plan B for Operation Warp Speed? Six months ago, we asked if vaccine makers were rushing to “check the box” rather than spending time designing an effective vaccine (here is another link showing ‘how to”). And have you noticed that all of...
by Danielle Medeiros | Aug 20, 2020 | Events, Featured
With the 2020 TIDES USA Virtual conference right around the corner, we at EpiVax are proud to sponsor this event, as we have year after year. Our CEO and leader in #FearlessScience Dr. Anne De Groot will be presenting a talk on a generic case study New Dogs/Old...
by Danielle Medeiros | Jun 8, 2020 | Featured, News
PROVIDENCE, RI, June 8, 2020 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) a Rhode Island-based company and recognized leader in the field in the field of immunogenicity assessment today announced it has licensed its advanced in silico toolkit for biologics...
by Danielle Medeiros | Jun 2, 2020 | Featured, News
Bilthoven, The Netherlands, Providence, R.I., USA, 2 June 2020 – Intravacc, one of the world’s leading translational research and development vaccine institutes, with an extensive track record in developing viral and bacterial vaccines, and EpiVax, a...
